antibiotic resistance 結果共1筆

Chinese children are increasingly experiencing antibiotic resistance when treating Mycoplasma pneumoniae, which poses a global health and economic concern. By 2050, drug-resistant diseases could result in healthcare costs of NT＄31 trillion and economic losses of up to NT＄106 trillion, according to the World Bank. The overuse of antibiotics has led to the rise of superbugs, diminishing the effectiveness of these medicines and compromising treatment outcomes. Azithromycin, a commonly used antibiotic in China for Mycoplasma pneumoniae, now faces an alarming resistance rate of nearly 80% to Macrolides. The World Health Organization (WHO) warns of the dangers of antibiotic overuse and refers to the situation as a ＂silent pandemic.＂ WHO Director-General Tedros Adhanom Ghebreyesus expresses concern that antibiotic resistance could bring us back to an era where minor infections are untreatable.